BEGIN:VCALENDAR VERSION:2.0 PRODID:-//142.1.176.180//NONSGML kigkonsult.se iCalcreator 2.26.9// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:https://engsci.utoronto.ca X-WR-TIMEZONE:America/Toronto BEGIN:VTIMEZONE TZID:America/Toronto X-LIC-LOCATION:America/Toronto BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 RDATE:20241103T020000 TZNAME:EST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 RDATE:20250309T020000 TZNAME:EDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-99222@engsci.utoronto.ca DTSTAMP:20240328T224026Z CATEGORIES;LANGUAGE=en-CA:Alumni Events CONTACT:https://alumni.engineering.utoronto.ca/events/ DESCRIPTION:5:30 p.m. – Virtual event opens\n5:40 p.m. – Disruptors & Dilem mas panel\n6:40 p.m. – Q&A\n7:00 p.m. – Event ends\n\n\n\nJoin us on Tuesd ay\, May 3rd for a special edition of Disruptors & Dilemmas\, featuring al umni and faculty from U of T Engineering\, the Leslie Dan Faculty of Pharm acy\, and the University of Toronto Mississauga. \nThe Future of Vaccine P roduction: Giving Canadian Biomanufacturing a Shot in the Arm\nThe COVID-1 9 pandemic exposed gaps in Canada’s preparedness to address great challeng es in the biomanufacturing space\, including domestic production of vaccin es. Disruptors & Dilemmas asks a panel of multi-disciplinary experts to pr ovide their insights on Canada’s response to COVID-19\, and how the fields of chemistry\, engineering\, and pharmacy are equipped to address future global crises. Through exciting initiatives at the University of Toronto a nd beyond\, our alumni and faculty hold the keys to unlocking the power of Canadian biomanufacturing to ensure that we are a world leader for the ne xt great challenge.\nThis free virtual speaker panel will be moderated by Claire Kennedy\, Co-Chair of the Defy Gravity Campaign and Former Chair of University of Toronto’s Governing Council. Guests will be invited to enga ge in Q&A with the panelists following the discussion.\n\n\n\nLearn about the panelists and register for the event here.\nTickets: https://alumni.en gineering.utoronto.ca/events/. DTSTART;TZID=America/Toronto:20220503T173000 DTEND;TZID=America/Toronto:20220503T190000 LOCATION:Online event SEQUENCE:0 SUMMARY:Disruptors & Dilemmas – The Future of Vaccine Production: Giving Ca nadian Biomanufacturing a Shot in the Arm URL:https://engsci.utoronto.ca/event/disruptors-dilemmas-future-vaccine/ X-COST-TYPE:external X-WP-IMAGES-URL:thumbnail\;https://engsci.utoronto.ca/wp-content/uploads/20 20/11/D_and_D_2020-150x150.png\;150\;150\;1\,medium\;https://engsci.utoron to.ca/wp-content/uploads/2020/11/D_and_D_2020-300x125.png\;300\;125\;1\,la rge\;https://engsci.utoronto.ca/wp-content/uploads/2020/11/D_and_D_2020.pn g\;680\;283\; X-ALT-DESC;FMTTYPE=text/html:\\n\\n
\\n5:30 p.m. – Virtual event opens
\n5:40 p.m. – Disruptors
& Dilemmas panel
\n6:40 p.m. – Q&A
\n7:00 p.m. – Event ends
Join us on Tuesday\, May 3rd strong> for a special edition of Disruptors & Dilemmas\, featuring alumni and faculty from U of T Engineering\, the Leslie Dan Faculty of Pharmacy\, and the University of Toronto Mississauga.
\nThe Future of Vaccine P roduction: Giving Canadian Biomanufacturing a Shot in the Arm
\nThe COVID-19 pandemic exposed gaps in Canada’s preparedness to a ddress great challenges in the biomanufacturing space\, including domestic production of vaccines. Disruptors & Dilemmas asks a panel of multi-disci plinary experts to provide their insights on Canada’s response to COVID-19 \, and how the fields of chemistry\, engineering\, and pharmacy are equipp ed to address future global crises. Through exciting initiatives at the Un iversity of Toronto and beyond\, our alumni and faculty hold the keys to u nlocking the power of Canadian biomanufacturing to ensure that we are a wo rld leader for the next great challenge.
\nThis free virtual speaker panel will be moderated by Claire Kennedy\, Co-Chair of the Defy Gravity Campaign and Former Chair of University of Toronto’s Governing Council. Gu ests will be invited to engage in Q&A with the panelists following the dis cussion.
\n